121 related articles for article (PubMed ID: 36189580)
1. Expression of Interleukin-21 and Interleukin-21 receptor in lymphocytes derived from tumor-draining lymph nodes of breast cancer.
Balouchi-Anaraki S; Mohammadsadeghi S; Norouzian M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Breast Dis; 2022; 41(1):373-382. PubMed ID: 36189580
[TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL)-21 and IL-21 receptor expression in peripheral T and B cells of patients with breast cancer.
Babaeinia E; Ghods A; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):15-22. PubMed ID: 38678632
[TBL] [Abstract][Full Text] [Related]
3. IFNγ-IL-17-IL-22+CD4+ subset and IL-22-producing cells in tumor draining lymph nodes of patients with breast cancer.
Salmanpour A; Rezaeifard S; Kiani R; Tahmasebi S; Faghih Z; Erfani N
Breast Dis; 2022; 41(1):383-390. PubMed ID: 36189579
[TBL] [Abstract][Full Text] [Related]
4. Significance of TIM-3 expression by CD4
Shariati S; Ghods A; Zohouri M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2020 Dec; 128():47-54. PubMed ID: 33068833
[TBL] [Abstract][Full Text] [Related]
5. TNFR2 but not TNFR1 is the main TNFR expressed by B and T lymphocytes in breast cancer draining lymph nodes.
Ghods A; Ghaderi A; Shariat M; Talei AR; Mehdipour F
Immunol Lett; 2019 May; 209():36-44. PubMed ID: 30910714
[TBL] [Abstract][Full Text] [Related]
6. The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors.
Shariati S; Mehdipour F; Samadi M; Rasolmali R; Talei AR; Ghaderi A
Life Sci; 2020 Sep; 257():118117. PubMed ID: 32693243
[TBL] [Abstract][Full Text] [Related]
7. Determination of a CD4
Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
[TBL] [Abstract][Full Text] [Related]
8. The significance of cytokine-producing B cells in breast tumor-draining lymph nodes.
Mehdipour F; Razmkhah M; Faghih Z; Bagheri M; Talei AR; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):381-395. PubMed ID: 30850950
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
10. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
11. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profile of CD4
Niakan A; Faghih Z; Talei AR; Ghaderi A
Mol Immunol; 2019 Dec; 116():90-97. PubMed ID: 31630080
[TBL] [Abstract][Full Text] [Related]
13. Memory CD4
Vahidi Y; Faghih Z; Talei AR; Doroudchi M; Ghaderi A
Cell Oncol (Dordr); 2018 Feb; 41(1):1-11. PubMed ID: 28994018
[TBL] [Abstract][Full Text] [Related]
14. [Tumor infiltrating regulatory T cells in human breast cancer and associated draining lymph nodes: an in-situ analysis].
Wang HY; Shi QF; Sun Y; He JJ; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):95-100. PubMed ID: 23710915
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
[TBL] [Abstract][Full Text] [Related]
16. Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes.
Arabpour M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2019 Oct; 114():172-178. PubMed ID: 31357083
[TBL] [Abstract][Full Text] [Related]
17. Correlation of 4-1BBL+ B Cells in Tumor Draining Lymph Nodes with Pathological Characteristics of Breast Cancer.
Arabpour M; Ghods A; Shariat M; Talei AR; Mehdipour F; Ghaderi A
Iran J Immunol; 2019 Jun; 16(2):108-116. PubMed ID: 31182685
[TBL] [Abstract][Full Text] [Related]
18. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets.
Van Belle TL; Nierkens S; Arens R; von Herrath MG
Immunity; 2012 Jun; 36(6):1060-72. PubMed ID: 22579473
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
